Abstract
A policy of selective implantation of drug eluting stents, in a minority of lesions most likely to benefit, seems to be a rational way to employ this new and currently costly technology.
Original language | English |
---|---|
Pages (from-to) | 127-131 |
Number of pages | 5 |
Journal | Heart |
Volume | 89 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 2003 |